I think the CTLA4 patent constitutes perhaps 85% of the entire company’s worth. RGEN may be worth a speculative buy on this premise alone, but I would not bet a lot on it. JMHO
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”